Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
It has been reported that human mesenchymal stem cells (MSCs) can transfer mitochondria to the cells with severely compromised mitochondrial function. We tested whether the reported intercellular mitochondrial transfer could be replicated in different types of cells or under different experimental conditions, and tried to elucidate possible mechanism. Using biochemical selection methods, we found exponentially growing cells in restrictive media (uridine(-) and bromodeoxyuridine [BrdU](+)) during the coculture of MSCs (uridine-independent and BrdU-sensitive) and 143B-derived cells with severe mitochondrial dysfunction induced by either long-term ethidium bromide treatment or short-term rhodamine 6G (R6G) treatment (uridine-dependent but BrdU-resistant). The exponentially growing cells had nuclear DNA fingerprint patterns identical to 143B, and a sequence of mitochondrial DNA (mtDNA) identical to the MSCs. Since R6G causes rapid and irreversible damage to mitochondria without the removal of mtDNA, the mitochondrial function appears to be restored through a direct transfer of mitochondria rather than mtDNA alone. Conditioned media, which were prepared by treating mtDNA-less 143B ρ(0) cells under uridine-free condition, induced increased chemotaxis in MSC, which was also supported by transcriptome analysis. Cytochalasin B, an inhibitor of chemotaxis and cytoskeletal assembly, blocked mitochondrial transfer phenomenon in the above condition. However, we could not find any evidence of mitochondrial transfer to the cells harboring human pathogenic mtDNA mutations (A3243G mutation or 4,977 bp deletion). Thus, the mitochondrial transfer is limited to the condition of a near total absence of mitochondrial function. Elucidation of the mechanism of mitochondrial transfer will help us create a potential cell therapy-based mitochondrial restoration or mitochondrial gene therapy for human diseases caused by mitochondrial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Changing potency by spontaneous fusion
Ying, Q.-L., Nichols, J., Evans, E. P., & Smith, A. G. (2002) · Nature · doi:10.1038/nature729 · Cited by 1,494
Ono, T., Isobe, K., Nakada, K., & Hayashi, J.-I. (2001) · Nature Genetics · doi:10.1038/90116 · Cited by 420 · cited 2×
“However, it has been suggested that mitochondrial diseases elicited by mtDNA mutations could be treated by exploiting the intermitochondrial complementation through exchange of genetic materials between mitochondria with normal and mutant mtDNAs [14,15] In this regard, the elucidation of the mechanism of the mitochond…”
Cited by
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
Phinney, D. G., Di Giuseppe, M., Njah, J., Sala, E., Shiva, S., St Croix, C. M., Stolz, D. B., Watkins, S. C., Di, Y. P., Leikauf, G. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9472 · Cited by 1,007
“However, the beneficial effects of mitochondria were limited to acceptor cells almost completely deficient of mitochondrial function 30, 53 .”
Tan, A. S., Baty, J. W., Dong, L.-F., Bezawork-Geleta, A., Endaya, B., Goodwin, J., Bajzikova, M., Kovarova, J., Peterka, M., Yan, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.003 · Cited by 785
Ahmad, T., Mukherjee, S., Pattnaik, B., Kumar, M., Singh, S., Kumar, M., Rehman, R., Tiwari, B. K., Jha, K. A., Barhanpurkar, A. P., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201386030 · Cited by 542
Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells
Wang, X., & Gerdes, H.-H. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.211 · Cited by 527
Mitochondria Know No Boundaries: Mechanisms and Functions of Intercellular Mitochondrial Transfer
Torralba, D., Baixauli, F., & Sánchez-Madrid, F. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00107 · Cited by 440
“…is triggered by an almost complete absence of mitochondrial function, such as mtDNA depletion or treatment with mitochondrial inhibitors, since transfer is not detected to cells harboring pathogenic mutations that partially affect mitochondrial function (Cho et al., 2012; Wang and Gerdes, 2015).”
BackgroundIntercellular mitochondrial transfer as a means of tissue revitalization
Liu, D., Gao, Y., Liu, J., Huang, Y., Yin, J., Feng, Y., Shi, L., Meloni, B. P., Zhang, C., Zheng, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00440-z · Cited by 403
Scheiblich, H., Dansokho, C., Mercan, D., Schmidt, S. V., Bousset, L., Wischhof, L., Eikens, F., Odainic, A., Spitzer, J., Griep, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.007 · Cited by 360
“Importantly, most of the work onmitochondrial transfer deals with the rescue of damaged cells (Ahmad et al., 2014; Cho et al., 2012; Islam et al., 2012) as it seems to be the case in our study.”
BackgroundGolpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 343
Regenerative abilities of mesenchymal stem cells through mitochondrial transfer
Paliwal, S., Chaudhuri, R., Agrawal, A., & Mohanty, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0429-1 · Cited by 334
Ionescu, L., Byrne, R. N., van Haaften, T., Vadivel, A., Alphonse, R. S., Rey-Parra, G. J., Weissmann, G., Hall, A., Eaton, F., & Thébaud, B. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2011 · Cited by 323
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Functional Mitochondria in Health and Disease
Herst, P. M., Rowe, M. R., Carson, G. M., & Berridge, M. V. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00296 · Cited by 323
Li, X., Zhang, Y., Yeung, S. C., Liang, Y., Liang, X., Ding, Y., Ip, M. S. M., Tse, H.-F., Mak, J. C. W., & Lian, Q. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0529oc · Cited by 303
Mahrouf-Yorgov, M., Augeul, L., Da Silva, C. C., Jourdan, M., Rigolet, M., Manin, S., Ferrera, R., Ovize, M., Henry, A., Guguin, A., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.51 · Cited by 291
Zhang, Y., Yu, Z., Jiang, D., Liang, X., Liao, S., Zhang, Z., Yue, W., Li, X., Chiu, S.-M., Chai, Y.-H., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.009 · Cited by 268
Wang, J., Liu, X., Qiu, Y., Shi, Y., Cai, J., Wang, B., Wei, X., Ke, Q., Sui, X., Wang, Y., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0554-z · Cited by 268
Mitochondria as a therapeutic target for ischemic stroke
He, Z., Ning, N., Zhou, Q., Khoshnam, S. E., & Farzaneh, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.11.005 · Cited by 267
Chang, J.-C., Wu, S.-L., Liu, K.-H., Chen, Y.-H., Chuang, C.-S., Cheng, F.-C., Su, H.-L., Wei, Y.-H., Kuo, S.-J., & Liu, C.-S. (2016) · Translational Research · doi:10.1016/j.trsl.2015.12.003 · Cited by 242
Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases
Liu, Z., Sun, Y., Qi, Z., Cao, L., & Ding, S. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00805-7 · Cited by 231
“More nuanced research through mitochondrial and cell staining and microscopy observations has shown that cell transfer intact mitochondrial, rather than purely mtDNA alone to help recipient cell mitochondrial function [10, 11].”
BackgroundResultScheiblich, H., Eikens, F., Wischhof, L., Opitz, S., Jüngling, K., Cserép, C., Schmidt, S. V., Lambertz, J., Bellande, T., Pósfai, B., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.029 · Cited by 207
Hsu, Y.-C., Wu, Y.-T., Yu, T.-H., & Wei, Y.-H. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.02.011 · Cited by 188
Metabolic Plasticity in Chemotherapy Resistance
Desbats, M. A., Giacomini, I., Prayer-Galetti, T., & Montopoli, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00281 · Cited by 183
“Horizontal transfer of mtDNA to cancer cells with a low respiratory function was correlated with recovery of respiration and increased tumor-initiating efficacy (281).”
BackgroundArtificial Mitochondria Transfer: Current Challenges, Advances, and Future Applications
Caicedo, A., Aponte, P. M., Cabrera, F., Hidalgo, C., & Khoury, M. (2017) · Stem Cells International · doi:10.1155/2017/7610414 · Cited by 150
Gomzikova, M. O., James, V., & Rizvanov, A. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653322 · Cited by 106
When Cells Become Organelle Donors
Rogers, R. S., & Bhattacharya, J. (2013) · Physiology · doi:10.1152/physiol.00032.2013 · Cited by 85
Age-related Changes in the Energy of Human Mesenchymal Stem Cells
Barilani, M., Lovejoy, C., Piras, R., Abramov, A. Y., Lazzari, L., & Angelova, P. R. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30638 · Cited by 31
“…one also involved in bone marrow niche homeostasis and therapeutic efficacy has been recently ascribed to horizontal transfer of mitochondria to damaged cells (Ahmad et al., 2014; Cho et al., 2012; Han et al., 2016; Hsu et al., 2016; Spees et al., 2006; Théry et al., 2018; Torralba et al., 2016).”
BackgroundWalecha, V., & Luthra, P. M. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04559-9 · Cited by 12
Metadata
- Authors
- Cho, Y. M., Kim, J. H., Kim, M., Park, S. J., Koh, S. H., Ahn, H. S., Kang, G. H., Lee, J.-B., Park, K. S., & Lee, H. K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-06
- Volume
- 7
- Issue
- 3
- Pages
- e32778
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2152706104
- Cited by
- 173
- References
- 3
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.